![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](dn6017contents.gif)
Acta Cryst. (2002). E58, o224-o226 [ doi:10.1107/S1600536802001952 ]
Methyl (2'R,3'R)-6-deoxy-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-2-O-toluene-p-sulfonyl-
-L-mannopyranoside
J. C. Barnes, J. S. Brimacombe, L. M. C. Connolly and A. P. Dix
Abstract: In the title compound, C20H30O9S, (III), both six-membered rings adopt chair conformations, placing H3 and the 2-sulfonyloxy group in the antiperiplanar arrangement required for an E2 reaction. However, unlike other
-mannopyranoside-2-sulfonates, the 2-O-trifluoromethylsulfonyl (trifluoromethanesulfonate) derivative, (II), underwent an SN2 displacement with an azide ion to give methyl (2'R,3'R)-2-azido-2,6-dideoxy-3,4-O-(2',3'-dimethoxybutane-2',3'-diyl)-
-L-glucopyranoside, (IV), in preference to the E2 reaction.
Online 8 February 2002
Copyright © International Union of Crystallography
IUCr Webmaster